Atea Pharmaceuticals Inc (NASDAQ: AVIR) Is A Great Opportunity For Risk-Tolerant Investors
Atea Pharmaceuticals Inc (NASDAQ:AVIR)’s traded shares stood at 0.55 million during the last session, with the company’s beta value hitting 0.17. At the close of